These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10073983)

  • 21. World Health Organization (WHO) and the World Heart Federation (WHF) Pathobiological Determinants of Atherosclerosis in Youth (PBDAY) Study. Lipid and raised lesion distribution in the right coronary artery of young people.
    Simoes C; Bianciardi G; Toti P; Weber G; Tanganelli P
    Nutr Metab Cardiovasc Dis; 1999 Dec; 9(6):277-83. PubMed ID: 10765519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical studies of C-reactive protein and apolipoprotein B in inflammatory and arterial lesions.
    Rowe IF; Walker LN; Bowyer DE; Soutar AK; Smith LC; Pepys MB
    J Pathol; 1985 Mar; 145(3):241-9. PubMed ID: 3884758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial characterization of lipoproteins containing apo[a] in human atherosclerotic lesions.
    Hoff HF; O'Neil J; Yashiro A
    J Lipid Res; 1993 May; 34(5):789-98. PubMed ID: 8509717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.
    Sharrett AR; Ballantyne CM; Coady SA; Heiss G; Sorlie PD; Catellier D; Patsch W;
    Circulation; 2001 Sep; 104(10):1108-13. PubMed ID: 11535564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated serum lipoprotein(a) in subclinical hypothyroidism.
    Kung AW; Pang RW; Janus ED
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):445-9. PubMed ID: 7586619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consistency of extended-release niacin/laropiprant effects on Lp(a), ApoB, non-HDL-C, Apo A1, and ApoB/ApoA1 ratio across patient subgroups.
    Bays HE; Shah A; Lin J; Sisk CM; Dong Q; Maccubbin D
    Am J Cardiovasc Drugs; 2012 Jun; 12(3):197-206. PubMed ID: 22500948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the quantitation of macrophage foam cell populations and the extent of apolipoprotein E deposition in developing atherosclerotic lesions in young people: high and low serum thiocyanate groups as an indication of smoking. PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth.
    Botti TP; Amin H; Hiltscher L; Wissler RW
    Atherosclerosis; 1996 Aug; 124(2):191-202. PubMed ID: 8830932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma concentrations of apolipoprotein A-I containing particles in normolipidaemic young men.
    Luc G; Parra HJ; Zylberberg G; Fruchart JC
    Eur J Clin Invest; 1991 Feb; 21(1):118-22. PubMed ID: 1830842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study.
    Erbel R; Lehmann N; Churzidse S; Möhlenkamp S; Moebus S; Mahabadi AA; Schmermund A; Stang A; Dragano N; Grönemeyer D; Seibel R; Kälsch H; Bauer M; Bröcker-Preuss M; Mann K; Jöckel KH;
    Atherosclerosis; 2013 Aug; 229(2):531-40. PubMed ID: 23701995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.
    McGill HC; McMahan CA; Malcom GT; Oalmann MC; Strong JP
    Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):431-40. PubMed ID: 7749853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression of apolipoprotein(a) within the wall of human aorta and carotid arteries.
    Fu L; Jamieson DG; Usher DC; Lavi E
    Atherosclerosis; 2001 Oct; 158(2):303-11. PubMed ID: 11583708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein A-II, HDL metabolism and atherosclerosis.
    Tailleux A; Duriez P; Fruchart JC; Clavey V
    Atherosclerosis; 2002 Sep; 164(1):1-13. PubMed ID: 12119188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study.
    Longenecker JC; Coresh J; Marcovina SM; Powe NR; Levey AS; Giaculli F; Fink NE; Klag MJ
    Am J Kidney Dis; 2003 Jul; 42(1):108-16. PubMed ID: 12830462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative contributions of apolipoprotein(a) and apolipoprotein-B to the development of fatty lesions in the proximal aorta of mice.
    Mancini FP; Newland DL; Mooser V; Murata J; Marcovina S; Young SG; Hammer RE; Sanan DA; Hobbs HH
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1911-6. PubMed ID: 7583571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study.
    Strong JP; Malcom GT; McMahan CA; Tracy RE; Newman WP; Herderick EE; Cornhill JF
    JAMA; 1999 Feb; 281(8):727-35. PubMed ID: 10052443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
    Hartgens F; Rietjens G; Keizer HA; Kuipers H; Wolffenbuttel BH
    Br J Sports Med; 2004 Jun; 38(3):253-9. PubMed ID: 15155420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cocaine: an independent risk factor for aortic sudanophilia. A preliminary report.
    Kolodgie FD; Virmani R; Cornhill JF; Herderick EE; Malcom GT; Mergner WJ
    Atherosclerosis; 1992 Nov; 97(1):53-62. PubMed ID: 1280144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apo B insertion/deletion polymorphisms are associated with atherosclerosis in young black but not young white males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.
    Hixson JE; McMahan CA; McGill HC; Strong JP
    Arterioscler Thromb; 1992 Sep; 12(9):1023-9. PubMed ID: 1525116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New atherosclerosis risk factors in obese, hypertensive and diabetic children and adolescents.
    Glowinska B; Urban M; Koput A; Galar M
    Atherosclerosis; 2003 Apr; 167(2):275-86. PubMed ID: 12818410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.